As of Nov 11, 2024, Johnson & Johnson Intrinsic Value is $159.2. This suggests it may be undervalued by 2.7% compared to its current price of around $155.0.
As of Nov 11, 2024, Johnson & Johnson's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $155.0, using a discount rate of 6.9% and terminal growth rate of 3.0%.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $159.2, compared to a market price of around $155.0. This suggests a potential undervaluation of 2.7%.